iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions
Newsfile Corp.
Newsfile Corp
Woburn, Massachusetts--(Newsfile Corp. - September 4, 2025) - iSpecimen Inc. (NASDAQ: ISPC), (the "Company"), a technology-enabled company modernizing the way human biospecimens are sourced for scientific research, today announced an update on its major strategic initiative aimed at integrating digital assets into its business model. The Company had previously announced that it is pursuing a strategic initiative aimed at integrating digital assets into its business model, by seeking to build an up to $200 million corporate treasury reserve based on the Solana blockchain ecosystem.
Since announcing its intentions in August, iSpecimen has been approached by several Crypto currency-related companies that have presented opportunities in tokenized real-world assets as well as among highly ranked cryptocurrencies. In a parallel path, the Company has continued meetings to build a Solana-based treasury program.
"We are refining our approach to build a digital asset treasury. While the acquisition of Locked Solana appeals, we recognize there are many opportunities that we continue to explore," commented Mr. Robert Lim CEO of iSpecimen.
As for Solana, iSpecimen plans to establish a SOL-based treasury program to diversify the Company's balance sheet and to support long-term growth initiatives. ISPC intends to source treasury management expertise to assist with policy design, counterparty diligence, execution, custody coordination, risk management, and reporting. The Company expects to fund the treasury program primarily from capital that may be raised from time to time.
To dive deeper, the Company's planned treasury program contemplates purchasing SOL (the native token of the Solana network) including, where appropriate, Locked SOL, through over-the-counter transactions with reputable cryptocurrency institutions. Any such purchases will be made only where legally transferable and following legal, regulatory, and counterparty due diligence. "Locked SOL" refers to SOL subject to contractual transfer or vesting restrictions; pricing may reflect a discount to prevailing spot prices to compensate for illiquidity and lock-up risk. The Company may also purchase unlocked SOL on regulated or reputable venues for liquidity management.
Mr. Lim continued, "We plan to deliver shareholder value primarily through a buy and HODL strategy as well as by purchasing locked SOL at a discount. We plan for the Solana to be staked including liquid staking tokenization to increase yields for shareholders in the long-term. Nevertheless, we also plan to partially diversify our Solana holding and allow a small percentage for spot trading." A HODL strategy is a long-term investment approach in Cryptocurrency to hold assets even in times of market volatility, rather than trying to time the market by frequently buying and selling.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
About iSpecimen
iSpecimen (NASDAQ: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. For more information, please visit www.ispecimen.com.
Safe Harbor Statement
Bullish
Market Data 
Markets 
AI
